z-logo
Premium
Impairment of oxidative stress‐induced heme oxygenase‐1 expression by the defect of Parkinson‐related gene of PINK1
Author(s) -
Chien WeiLin,
Lee TzengRuei,
Hung ShihYa,
Kang KaiHsiang,
Lee MingJen,
Fu WenMei
Publication year - 2011
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.2011.07229.x
Subject(s) - pink1 , oxidative stress , protein kinase b , heme oxygenase , gene knockdown , biology , microbiology and biotechnology , chemistry , cancer research , phosphorylation , biochemistry , heme , apoptosis , autophagy , enzyme , mitophagy
J. Neurochem. (2011) 117 , 643–653. Abstract Parkinson’s disease (PD) is one of the most common neurodegenerative diseases. Mutation in the phosphatase and tensin homolog (PTEN)‐induced putative kinase 1 (PINK1) gene causes an autosomal recessive form of PD. However, the etiology related to PINK1 is still not clear. Here, we examined the effect of PINK1 on heme oxygenase (HO)‐1 induction in SH‐SY5Y neuronal cells following H 2 O 2 or 1‐methyl‐4‐phenylpyridinium (MPP + ) treatment. The HO‐1 induction in response to H 2 O 2 and MPP + treatment was impaired by the expression of recombinant PINK1 G309D mutant. PINK1 G309D mutation increased the apoptosis of SH‐SY5Y cells following H 2 O 2 treatment and cell survival was rescued by the over‐expression of HO‐1 using adenovirus (Ad) infection. In addition, knockdown of tumor necrosis factor receptor‐associated protein‐1 (TRAP1), which is the substrate of PINK1 kinase, in SH‐SY5Y cells also inhibited the expression of HO‐1 in response to oxidative stress. The up‐regulation of TRAP1 expression following H 2 O 2 treatment was inhibited by the expression of recombinant PINK1 G309D mutant. The H 2 O 2 ‐induced HO‐1 induction was Akt‐ and ERK‐dependent. The phosphorylation of ERK and Akt but not p38 was inhibited in cells expressing the PINK1 G309D mutant and knockdown of TRAP1. These results indicate a novel pathway by which the defect of PINK1 inhibits the oxidative stress‐induced HO‐1 production. Impairment of HO‐1 production following oxidative stress may accelerate the dopaminergic neurodegeneration in Parkinson patients with PINK1 defect.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here